(Q80785300)
Statements
Assessment of the biological and pharmacological effects of the alpha nu beta3 and alpha nu beta5 integrin receptor antagonist, cilengitide (EMD 121974), in patients with advanced solid tumors (English)
S Hariharan
D Gustafson
S Holden
D McConkey
D Davis
M Morrow
M Basche
L Gore
C Zang
C L O'Bryant
A Baron
D Gallemann
D Colevas